drugset / Trial / NCT01591785

Treatment of Staphylococcus Aureus Colonization in Hand Eczema

NCT01591785

Completed 60 enrolled Gary Goldenberg
RandomizedParallel-groupDouble-blindTreatment

Summary

Atopic dermatitis is a chronic disease characterized by itching and eczematous lesions. In adults, eczema commonly localizes to the hands or feet. Several studies have implicated bacterial contamination, especially with Staphylococcus aureus (S. aureus), to be a factor in atopic dermatitis, as infection with this bacteria correlates with disease severity. No trial to date has investigated how to treat S. aureus infection in adults with hand or hand/foot dermatitis. Using retapamulin ointment in the nose and on the hands or hands/feet, the investigators expect to have a significant clearance rate of s. aureus infection. The investigators believe that treating the bacterial infection along with treating the condition with a topical corticosteroid will significantly decrease the severity of hand/foot dermatitis in our study population.

Timeline

Start
2012-01
Primary completion
2012-08
Completion
2012-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Retapamulin Small molecule 1 % Topical
Comparator clobetasol propionate Small molecule 0.05 % Topical